Anne Paju
Tallinn University of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anne Paju.
Tetrahedron Letters | 1996
Margus Lopp; Anne Paju; Tõnis Kanger; Tõnis Pehk
Abstract The asymmetric Baeyer-Villiger oxidation of racemic cyclobutanones 1, 2, and 3 and a prochiral cyclobutanone 4 under Sharpless oxidation conditions resulted in the enantiomeric lactones 5 ee 34%, 6 ee 53%, 7 ee 75% and 8 40% ee respectively.
Tetrahedron-asymmetry | 1998
Tõnis Kanger; Kadri Kriis; Anne Paju; Tõnis Pehk; Margus Lopp
Abstract Oxidation of prochiral and racemic cyclobutanones with t-BuOOH and Ti–TADDOL-based complexes afforded lactones in up to 44% ee. The enantioselectivity of the reaction clearly depends on the amount of the reagent and the highest enantioselectivities were obtained with stoichiometric amounts of the complex. Modification of the TADDOL structure and use of the mixed complex derived from TADDOL and a tartaric ester led to more reactive but less selective oxidation systems.
Tetrahedron-asymmetry | 2003
Anne Paju; Tõnis Kanger; Tõnis Pehk; Rasmus Lindmaa; Aleksander-Mati Müürisepp; Margus Lopp
Abstract Ti(O i Pr) 4 /diethyl tartrate/ t BuOOH system oxidizes 3-alkyl-1,2-cyclopentanediones resulting in hydroxylated ring cleavage products 2-alkyl-γ-lactone acids, in high enantioselectivity (∼95% ee) and satisfactory isolated yields (up to 55%).
Tetrahedron Letters | 2000
Anne Paju; Tõnis Kanger; Tõnis Pehk; Margus Lopp
Abstract Cyclic 3-alkyl-1,2-cyclopentanediones undergo a direct asymmetric oxidation with the DET/Ti(OiPr)4/tBuOOH oxidative system, resulting in enantiomeric α-hydroxy compounds and ring-cleaved hydroxylated acids (lactones) up to 95% ee.
Tetrahedron Letters | 1997
Margus Lopp; Anne Paju; Tõnis Kanger; Tõnis Pehk
Abstract Direct oxidation of racemic β-hydroxyketones 1a-c under Sharpless oxidation conditions resulted in the enantiomeric α,β-dihydroxyketones 2a in 97% ee, 2b in 86% ee and 2c in 95% ee respectively, in 37–58% of isolated yield. The oxidation is assumed to proceed via an allylic enolate intermediate.
Tetrahedron-asymmetry | 2002
Anne Paju; Tõnis Kanger; Tõnis Pehk; Aleksander-Mati Müürisepp; Margus Lopp
Abstract 3-Alkyl-1,2-cyclopentanediones undergo asymmetric 3-hydroxylation with the Sharpless Ti-complex resulting in enantiomeric 3-hydroxy carbonyl compounds with ee up to 95% in yields of 22–40%.
Nucleosides, Nucleotides & Nucleic Acids | 2010
Anne Paju; M. Päri; Anastasia Selyutina; Eva Žusinaite; Andres Merits; Tõnis Pehk; K. Siirde; A.-M. Müürisepp; T. Kailas; Margus Lopp
A series of novel acyclic thymine nucleoside analogues were prepared by the Mitsunobu reaction from appropriately protected chiral triols. The enantiomeric triols were obtained from substituted γ-lactone acids, prepared by asymmetric oxidation of 3-substituted-1,2-cyclopentanediones. The cytotoxic activity of new analogues was evaluated on MCF-7 human breast cancer and HeLa cells, and antiviral activities on human immunodeficiency virus type 1 and hepatitis C virus models. The synthesized compounds revealed specific anti-retroviral activity and no cytotoxic side effects.
Tetrahedron | 2002
Anne Paju; Tõnis Kanger; Tõnis Pehk; Margus Lopp
A direct α-hydroxylation of racemic 2-hydroxymethyl ketones with the Sharpless epoxidation catalyst resulted in α,β-dihydroxy ketones in high ee (up to 97%) and in moderate to good isolated yield (up to 58%).
Tetrahedron-asymmetry | 2003
Anne Paju; Tõnis Kanger; Olivia Niitsoo; Tõnis Pehk; Aleksander-Mati Müürisepp; Margus Lopp
Abstract A Ti(O i Pr) 4 /diethyl tartrate/ t BuOOH complex oxidizes 3-hydroxyethyl-1,2-cyclopentanediones, resulting in hydroxylated/ring cleavage products—lactone acids of high enantioselectivity (up to 95% ee) with good yields (up to 75%). These compounds are converted into chiral spiro-γ-dilactones in good yield.
Tetrahedron | 1995
Anne Paju; Alo Soone; Tõnis Pehk; Margus Lopp
Abstract A synthesis of 7[3(3R-hydroxy-3-cyclohexyl-l-propyl)-7-oxa-lS,2S,3S,4-R-bicyclo[2.2.1]-heptan-2-yl-5Z-heptenoic acid 1, an ω-chain saturated analogue of Thromboxane A2 is described. The relative and the absolute configurations of the intermediates and the target compound were determined by 2D FT NMR methods.